Literature DB >> 12523470

Evidence of the economic benefit of clinical pharmacy services: 1996-2000.

Glen T Schumock1, Melissa G Butler, Patrick D Meek, Lee C Vermeulen, Bhakti V Arondekar, Jerry L Bauman.   

Abstract

We sought to summarize and assess original evaluations of the economic impact of clinical pharmacy services published from 1996-2000, and to provide recommendations and methodologic considerations for future research. A systematic literature search was conducted to identify articles that were then blinded and randomly assigned to reviewers who confirmed inclusion and abstracted key information. Results were compared with those of a similar review of literature published from 1988-1995. In the 59 included articles, the studies were conducted across a variety of practice sites that consisted of hospitals (52%), community pharmacies and clinics (41%), health maintenance organizations (3%), and long-term or intermediate care facilities (3%). They focused on a broad range of clinical pharmacy services such as general pharmacotherapeutic monitoring (47%), target drug programs (20%), disease management programs (10%), and patient education or cognitive services (10%). Compared with the studies of the previous review, a greater proportion of evaluations were conducted in community pharmacies or clinics, and the types of services evaluated tended to be more comprehensive rather than specialized. Articles were categorized by type of evaluation: 36% were considered outcome analyses, 24% full economic analyses, 17% outcome descriptions, 15% cost and outcome descriptions, and 8% cost analyses. Compared with the studies of the previous review, a greater proportion of studies in the current review used more rigorous study designs. Most studies reported positive financial benefits of the clinical pharmacy service evaluated. In 16 studies, a benefit:cost ratio was reported by the authors or was able to be calculated by the reviewers (these ranged from 1.7:1-17.0:1, median 4.68:1). The body of literature from this 5-year period provides continued evidence of the economic benefit of clinical pharmacy services. Although the quality of study design has improved, whenever possible, future evaluations of this type should incorporate methodologies that will further enhance the strength of evidence of this literature and the conclusions that may be drawn from it.

Entities:  

Mesh:

Year:  2003        PMID: 12523470     DOI: 10.1592/phco.23.1.113.31910

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  52 in total

1.  The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark.

Authors:  Thomas Croft Buck; Lene Brandstrup; Ivan Brandslund; Jens Peter Kampmann
Journal:  Pharm World Sci       Date:  2007-02

2.  Pharmacy interns on the ward--a pilot study.

Authors:  Andrea Gerdemann; Nina Griese; Martin Schulz
Journal:  Pharm World Sci       Date:  2007-02

3.  Validation of an instrument for the documentation of clinical pharmacists' interventions.

Authors:  Benoît Allenet; Pierrick Bedouch; François-Xavier Rose; Laurence Escofier; Renaud Roubille; Bruno Charpiat; Michel Juste; Ornella Conort
Journal:  Pharm World Sci       Date:  2006-10-26

4.  Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital.

Authors:  Markus L Lampert; Stephan Kraehenbuehl; Balthasar L Hug
Journal:  Pharm World Sci       Date:  2008-03-21

5.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

6.  Development of Clinical Pharmacy services at King Khalid University Hospital and its impact on the quality of healthcare provided.

Authors:  Abdulaziz A Saddique
Journal:  Saudi Pharm J       Date:  2012-05-11       Impact factor: 4.330

7.  Clinical pharmacists' interventions in a German university hospital.

Authors:  Claudia Langebrake; Heike Hilgarth
Journal:  Pharm World Sci       Date:  2010-01-19

8.  Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital.

Authors:  Austin R Campbell; Leigh Anne Nelson; Ellie Elliott; Robin Hieber; Roger W Sommi
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

9.  What is holding pharmacists back?

Authors:  Joshua Torrance
Journal:  Can Pharm J (Ott)       Date:  2014-09

10.  Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model.

Authors:  Adria Nogueras; Maria Isabel Chinchilla Fernández; Fernando Martínez; Faus Maria Jose; José Manuel Martínez Sesmero; José Luis Poveda Andrés; Miguel Ángel Calleja
Journal:  Eur J Hosp Pharm       Date:  2019-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.